According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 4.83%. At the end of 2022 the company had an Operating Margin of 7.14%.
Year | Operating Margin | Change |
---|---|---|
2022 | 7.14% | -274.85% |
2021 | -4.08% | 79.41% |
2020 | -2.27% | -59.11% |
2019 | -5.56% | -41.86% |
2018 | -9.57% | 250.42% |
2017 | -2.73% | -96.33% |
2016 | -74.41% | 327.97% |
2015 | -17.39% | 4.58% |
2014 | -16.63% | -48.33% |
2013 | -32.18% | 36.23% |
2012 | -23.62% | 138.97% |
2011 | -9.88% | 73.07% |
2010 | -5.71% | -3376.03% |
2009 | 0.17% | -98.45% |
2008 | 11.27% | -190.92% |
2007 | -12.40% | -57.68% |
2006 | -29.30% | -88.29% |
2005 | -250.16% | -68.47% |
2004 | -793.48% | 26.66% |
2003 | -626.47% | 28.95% |
2002 | -485.84% | 41.03% |
2001 | -344.49% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Sanofi SNY | 18.21% | 277.02% | ๐ซ๐ท France |
Ultragenyx RARE | -162.16% | -3,457.35% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | -160.78% | -3,428.78% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | -343.04% | -7,202.28% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | -55.07% | -1,240.17% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | 48.88% | 912.01% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.